Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma

Sheng Huei Yang, Hung Yun Lin, Chun A. Changou, Chun Han Chen, Yun Ru Liu, Jinghan Wang, Xiaoqing Jiang, Frank Luh, Yun Yen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Human intrahepatic cholangiocarcinomas are one of the most difficult cancers to treat. In our study, Lovastatin, a 3-hydroxy-3-methylglutaryl-coenzyme-CoA (HMG-CoA) reductase inhibitor, demonstrated anticancer properties by inhibiting cancer cell proliferation, cell migration and cell adhesion. Lovastatin inhibited the expressions of transforming growth factor (TGF)-β1, cyclooxygenase (COX)-2, and intercellular adhesion molecule (ICAM)-1. Furthermore, lovastatin inhibited the expressions of integrin β1 and integrin β3 but not integrin αv or integrin β5. While Lovastatin's inhibitory effects on TGFβ1, COX2, and ICAM-1 expression were independently controlled by the tumor suppressor LKB1, integrin β3 expression was not affected. Lovastatin's inhibitory effect on cell adhesion was associated with the decreased expression of integrin β3 and cell surface heterodimer integrin αvβ3. Quantitative real time PCR, fluorescent microscopy, and cell migration assays all confirmed that Lovastatin inhibits integrin αvβ3 downstream signaling including FAK activation, and β-catenin, vimentin, ZO-1, and β-actin. Overall, Lovastatin reduced tumor cell proliferation and migration by modifying the expression of genes involved in cell adhesion and other critical cellular processes. Our study highlights novel anti-cancer properties of Lovastatin and supports further exploration of statins in the context of cholangiocarcinoma therapy.

Original languageEnglish
Pages (from-to)362-373
Number of pages12
JournalOncotarget
Volume7
Issue number1
DOIs
Publication statusPublished - 2016

Keywords

  • Bile duct cancer
  • HMG-CoA reductase inhibitor
  • Integrin
  • LKB1
  • TGF-β1

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma'. Together they form a unique fingerprint.

  • Cite this